Development and evaluation of a WeChat-based intervention program for prevention of breast cancer-related lymphedema
- PMID: 39663241
- DOI: 10.1007/s00520-024-09078-x
Development and evaluation of a WeChat-based intervention program for prevention of breast cancer-related lymphedema
Abstract
Purpose: Mobile health applications have been widely adopted among breast cancer survivors for disease management; however, their use specifically for the prevention of breast cancer-related lymphedema (BCRL) remains sparse. This study is aimed at developing a WeChat-based intervention program for the prevention of BCRL based on the common-sense model (CSM).
Methods: This study was designed based on intervention mapping. First, a longitudinal investigation was conducted to determine the predictive effect of illness perception on BCRL prevention behaviors among breast cancer survivors. An intervention program was then constructed based on the CSM and longitudinal results. Finally, a WeChat mini-program was developed, and 15 patients were recruited to test its usability and user satisfaction through usability tests based on typical tasks and the Post-Study System Usability Questionnaire (PSSUQ), respectively.
Results: The longitudinal study revealed that identity, personal control, illness coherence, and behavioral and physical factors in the causes dimension could positively predict prevention behaviors, whereas treatment control and uncontrollable factors exhibited negative predictive effects. This study then developed an individualized intervention program and a WeChat mini-program (named "Nantian e-Care") consisting of five modules: "resources," "questionnaires," "homepage," "consultation," and "personal center." Patients could read BCRL-related educational content, watch functional exercise videos, self-measure arm circumference, and consult questions. The five-task completion rates were 80.00 ~ 100.00%, the average completion time was 9.47 ~ 33.31 s, and the scores of PSSUQ were greater than 5 points (full score 7 points).
Conclusions: This study proposed a feasible intervention program for the prevention of BCRL and developed a customized WeChat mini-program with high usability and user satisfaction.
Trial registration: Chinese Clinical Trial Registry, URL: https://www.chictr.org.cn/ , ChiCTR2100048798.
Keywords: Breast cancer lymphedema; Perception; Prevention and control; Risk reduction behavior; Telemedicine.
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
Declarations. Ethics approval: This study was approved by the Ethics Committee of the Affiliated Hospital of Sun Yat-sen University (L2019ZSLYEC-001). All participants were informed of the purpose and content of the study and provided written informed consent. Consent to participate: Informed consent was obtained from all the participants in this study. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Similar articles
-
Lymphedema self-management mobile application with nurse support for post breast cancer surgery survivors: description of the design process and prototype evaluation.BMC Cancer. 2024 Aug 8;24(1):973. doi: 10.1186/s12885-024-12744-2. BMC Cancer. 2024. PMID: 39118042 Free PMC article.
-
Illness perceptions and adherence to breast cancer-related lymphedema risk management behaviours among breast cancer survivors.Eur J Oncol Nurs. 2022 Jun;58:102144. doi: 10.1016/j.ejon.2022.102144. Epub 2022 Apr 18. Eur J Oncol Nurs. 2022. PMID: 35487156
-
Utilization of bioelectrical impedance analysis for detection of lymphedema in breast Cancer survivors: a prospective cross sectional study.BMC Cancer. 2019 Jul 8;19(1):669. doi: 10.1186/s12885-019-5840-9. BMC Cancer. 2019. PMID: 31286884 Free PMC article.
-
Advances in the prevention and treatment of breast cancer-related lymphedema.Breast Cancer Res Treat. 2023 Jul;200(1):1-14. doi: 10.1007/s10549-023-06947-7. Epub 2023 Apr 27. Breast Cancer Res Treat. 2023. PMID: 37103598 Free PMC article. Review.
-
Current Diagnostic Tools for Breast Cancer-Related Lymphedema.Curr Oncol Rep. 2023 Mar;25(3):151-154. doi: 10.1007/s11912-023-01357-w. Epub 2023 Jan 25. Curr Oncol Rep. 2023. PMID: 36696076 Review.
Cited by
-
Fear of cancer recurrence among adolescent and young adult cancer survivors: a mixed-methods systematic review.J Cancer Surviv. 2025 Apr 22. doi: 10.1007/s11764-025-01812-6. Online ahead of print. J Cancer Surviv. 2025. PMID: 40263195 Review.
References
-
- McDuff SGR, Mina AI, Brunelle CL et al (2019) Timing of lymphedema after treatment for breast cancer: when are patients most at risk? Int J Radiat Oncol Biol Phys 103(1):62–70. https://doi.org/10.1016/j.ijrobp.2018.08.036 - DOI - PubMed
-
- Hemati M, Rivaz M, Khademian Z (2024) Lymphedema self-management mobile application with nurse support for post breast cancer surgery survivors: description of the design process and prototype evaluation. BMC Cancer 24(1):973. https://doi.org/10.1186/s12885-024-12744-2 - DOI - PubMed - PMC
-
- McEvoy MP, Ravetch E, Patel G et al (2021) Prevention of breast cancer-related lymphedema. Clin Breast Cancer 21(2):128–142. https://doi.org/10.1016/j.clbc.2021.02.009 - DOI - PubMed
-
- American Cancer Society (2021) For people at risk of lymphedema [EB/OL]. https://www.cancer.org/treatment/treatments-and-side-effects/physical-si... . Accessed 20 Mar 2024
-
- National Cancer Institute (2020) Lymphedema and cancer treatment [EB/OL]. https://www.cancer.gov/about-cancer/treatment/side-effects/lymphedema . Accessed 20 Mar 2024
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources